{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:02Z","timestamp":1786984382526,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.annpat.2017.10.015","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T22:39:23Z","timestamp":1514068763000},"page":"7-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Histopathologie des r\u00e9actions cutan\u00e9es m\u00e9dicamenteuses"],"prefix":"10.1016","volume":"38","author":[{"given":"Nicolas","family":"Ortonne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2017.10.015_bib0130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2222.2007.02742.x","article-title":"Delayed drug hypersensitivity reactions \u2013 new concepts","volume":"37","author":"Posadas","year":"2007","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0135","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B*1502\u00a0allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0140","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801\u00a0allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.annpat.2017.10.015_bib0145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701\u00a0screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.annpat.2017.10.015_bib0150","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.annpat.2017.10.015_bib0155","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med."},{"key":"10.1016\/j.annpat.2017.10.015_bib0160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95\u00a0with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science."},{"key":"10.1016\/j.annpat.2017.10.015_bib0165","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2133.2009.09627.x","article-title":"Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases","volume":"162","author":"Bell\u00f3n","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0625.2010.01176.x","article-title":"Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis","volume":"20","author":"de Araujo","year":"2011","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.annpat.2017.10.015_bib0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008227","article-title":"An annexin A1-FPR1\u00a0interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions","volume":"6","author":"Saito","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.annpat.2017.10.015_bib0180","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol."},{"key":"10.1016\/j.annpat.2017.10.015_bib0185","first-page":"8071","article-title":"Defective regulatory T\u00a0cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.annpat.2017.10.015_bib0190","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2133.2008.08516.x","article-title":"In vivo dynamics of intraepidermal CD8+ T\u00a0cells and CD4+ T\u00a0cells during the evolution of fixed drug eruption","volume":"158","author":"Mizukawa","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0195","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/bjd.14704","article-title":"Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward","volume":"175","author":"Pinto Gouveia","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0200","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14986","article-title":"Is DRESS syndrome a single entity or within a spectrum of adverse reactions to drug?","volume":"175","author":"Ortonne","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0205","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)64410-0","article-title":"Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T\u00a0cells residing at an effector site of immunopathology in fixed drug eruption","volume":"161","author":"Mizukawa","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","author":"Duong","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.annpat.2017.10.015_bib0215","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0220","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2008.09.015","article-title":"Cutaneous drug eruptions: a 5-year experience","volume":"59","author":"Gerson","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjd.13683","article-title":"Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study","volume":"173","author":"Ortonne","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0230","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2010.09967.x","article-title":"The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102\u00a0cases","volume":"163","author":"Halevy","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0235","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.jaad.2011.10.007","article-title":"Prognostic value of histologic features of toxic epidermal necrolysis","volume":"68","author":"Valeyrie-Allanore","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0240","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.2006.07332.x","article-title":"Reactivation of human herpesvirus (HHV) family members other than HHV-6\u00a0in drug-induced hypersensitivity syndrome","volume":"155","author":"Seishima","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annpat.2017.10.015_bib0245","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T\u00a0cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.annpat.2017.10.015_bib0125","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000956","article-title":"Expression of TFH markers and detection of RHOA p.G17V and IDH2\u00a0p.R172K\/S mutations in cutaneous localizations of angioimmunoblastic T-cell lymphomas","author":"Leclaire Alirkilicarslan","year":"2017","journal-title":"Am J Surg Pathol"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649817301815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649817301815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:33:45Z","timestamp":1759332825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649817301815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0242649817301815"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2017.10.015","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathologie des r\u00e9actions cutan\u00e9es m\u00e9dicamenteuses","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2017.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}